van der Reijden BA - Search Results

1

A novel, essential control for clonality analysis with human androgen receptor gene polymerase chain reaction.

van Dijk JP, Heuver LH, van der Reijden BA, Raymakers RA, de Witte T, Jansen JH. van Dijk JP, et al. Among authors: van der reijden ba. Am J Pathol. 2002 Sep;161(3):807-12. doi: 10.1016/S0002-9440(10)64240-X. Am J Pathol. 2002. PMID: 12213708 Free PMC article.

2

Acute leukemias with structurally altered core binding factor subunits (t(8;21), inv(16), t(12;21)), 27-28 June 1997, Rotterdam, The Netherlands.

van der Reijden BA, Bloomfield CD, Touw IP, Jansen JH. van der Reijden BA, et al. Leukemia. 1997 Dec;11(12):2217-9. Leukemia. 1997. PMID: 9447846

3

Rapid simultaneous screening of factor V Leiden and G20210A prothrombin variant by multiplex polymerase chain reaction on whole blood.

Gomez E, van der Poel SC, Jansen JH, van der Reijden BA, Lowenberg B. Gomez E, et al. Among authors: van der reijden ba, van der poel sc. Blood. 1998 Mar 15;91(6):2208-9. Blood. 1998. PMID: 9490710 Free article. No abstract available.

4

TRIADs: a new class of proteins with a novel cysteine-rich signature.

van der Reijden BA, Erpelinck-Verschueren CA, Löwenberg B, Jansen JH. van der Reijden BA, et al. Protein Sci. 1999 Jul;8(7):1557-61. doi: 10.1110/ps.8.7.1557. Protein Sci. 1999. PMID: 10422847 Free PMC article.

5

Molecular remission of Philadelphia/bcr-abl-positive acute myeloid leukaemia after treatment with anti-CD33 calicheamicin conjugate (gemtuzumab ozogamicin, CMA-676).

de Vetten MP, Jansen JH, van der Reijden BA, Berger MS, Zijlmans JM, Löwenberg B. de Vetten MP, et al. Among authors: van der reijden ba. Br J Haematol. 2000 Oct;111(1):277-9. doi: 10.1046/j.1365-2141.2000.02402.x. Br J Haematol. 2000. PMID: 11091212 Free article.

6

Degradable dU-based DNA template as a standard in real-time PCR quantitation.

Pennings JL, Van De Locht LT, Jansen JH, Van der Reijden BA, De Witte T, Mensink EJ. Pennings JL, et al. Among authors: van de locht lt, van der reijden ba. Leukemia. 2001 Dec;15(12):1962-5. doi: 10.1038/sj.leu.2402290. Leukemia. 2001. PMID: 11753618

7

Identification of a novel CBFB-MYH11 transcript: implications for RT-PCR diagnosis.

Van der Reijden BA, de Wit L, van der Poel S, Luiten EB, Lafage-Pochitaloff M, Dastugue N, Gabert J, Löwenberg B, Jansen JH. Van der Reijden BA, et al. Among authors: van der poel s. Hematol J. 2001;2(3):206-9. doi: 10.1038/sj.thj.6200103. Hematol J. 2001. PMID: 11920247

8

Minimal residual disease quantification in patients with acute myeloid leukaemia and inv(16)/CBFB-MYH11 gene fusion.

van der Reijden BA, Simons A, Luiten E, van der Poel SC, Hogenbirk PE, Tönnissen E, Valk PJ, Löwenberg B, De Greef GE, Breuning MH, Jansen JH. van der Reijden BA, et al. Among authors: van der poel sc. Br J Haematol. 2002 Aug;118(2):411-8. doi: 10.1046/j.1365-2141.2002.03738.x. Br J Haematol. 2002. PMID: 12139724 Free article.

9

Rapid identification of CBFB-MYH11-positive acute myeloid leukemia (AML) cases by one single MYH11 real-time RT-PCR.

van der Reijden BA, Massop M, Tönnissen E, van de Locht L, Muus P, de Witte T, Jansen JH. van der Reijden BA, et al. Among authors: van de locht l. Blood. 2003 Jun 15;101(12):5085-6. doi: 10.1182/blood-2003-02-0405. Blood. 2003. PMID: 12788791 Free article. No abstract available.

10

Bcl-2 prevents loss of mitochondria in CCCP-induced apoptosis.

de Graaf AO, van den Heuvel LP, Dijkman HB, de Abreu RA, Birkenkamp KU, de Witte T, van der Reijden BA, Smeitink JA, Jansen JH. de Graaf AO, et al. Among authors: van der reijden ba, van den heuvel lp. Exp Cell Res. 2004 Oct 1;299(2):533-40. doi: 10.1016/j.yexcr.2004.06.024. Exp Cell Res. 2004. PMID: 15350550

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

131 results

Search Page